effect overlay
activetrials
Multiple Sclerosis

A Phase IIIb Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults with Primary Progressive Multiple Sclerosis
 

HREC: 2019.072
Principal Investigator: Dr Chris Dwyer
Coordinator contact: Hasini Fernando
Funding: Commercial
Multiple Sclerosis

Role of free circulating mitochondria in the pathogenesis of Multiple Sclerosis
 

HREC: 2019.111
Principal Investigator: Dr Mastura Monif
Coordinator contact: Dr Mastura Monif
Funding: Non-Commercial
Multiple Sclerosis

Autoimmune encephalitis and other neuroinflammatory conditions
 

HREC: 2019.140
Principal Investigator: Dr Mastura Monif
Coordinator contact:
Funding: Non-Commercial

The Biomarker Research in StroKe (BRISK) Registry
 

HREC: 2017.005
Principal Investigator: Prof Bernard Yan
Coordinator contact: Laura Fisicchia
Funding: Non-Commercial

Melbourne Mobile Stroke Unit (MSU) Implementation Program Evaluation including Cost-Effectiveness
 

HREC: 2017.456
Principal Investigator: Dr Henry Zhao
Coordinator contact:
Funding: Non-Commercial